The story has been corrected to say that the Nasdaq Biotechnology Index rose 7 percent in February, not 10 percent. We apologize for for the mistake. 

NEW YORK (360Dx) — Foundation Medicine, Invitae, Accelerate Diagnostics, and Myriad Genetics each saw their share prices jump more than 20 percent in February to pace the gainers in the 360Dx Index last month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.